维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Thomas RZ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Toxicity criteria of the Radiation Therapy Oncology Group (HTOG) and European Organiza tion for Research and Treatment of Cancer (EORTC)显示文摘	James D Joann-Stetz RZ Thomas FP	1995	Int J Radiat Oncol Biol Phys1995，31，：	1
2	Red Autofluorescence of Dental Plaque Bacteria显示文摘	van der Veen MH Thomas RZ	2006	Caries Res2006，40，：	1
3	Approximal secondary caries lesion progression, a 20-week in situ study显示文摘	Thomas RZ Ruben JL ten Bosch JJ	2007	Caries Res2007，41，5：	1
4	Bacterial composition and red fluorescence of plaque in relation to primary and secondary caries next to composite: An in situ study显示文摘	Thomas RZ van der Mei HC van der Veeu MH	2008	Oral Microbiol Immunol2008，23，1：	1
5	Bacterial composition and red fluorescence of plaque in relation to primary and secondary caries next to composite: an in situ study显示文摘	Thomas RZ van der Mei HC van der Veen MH	2008	Oral Microbiol Immunol2008，23，1：	1
6	Role of combination bortezomib and pegylated liposomal doxorubicin in the management of re- lapsed and/or refractory muhiple myeloma 显示文摘	Shah JJ Orlowski RZ Thomas SK	2009	Ther Clin Risk Manag2009，5，1：	1
7	Metabolic effect of recom- bi-nant human growth hormone in patients receiving parenteral nutrition 显示文摘	Thomas RZ Lorraine S Young RD	1988	Ann Surg1988，208，：	1
8	Bac-terial composition and red fluorescence of plaque in relationto primary and secondary caries next to composite:an insitu study显示文摘	Thomas RZ van der Mei HC van der Veen MH	2008	Oral Microbiol Immunol2008，23，1：	1
9	Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors 显示文摘	Thomas JP Arzoomanian RZ Alberti D	2003	Clin Oncol2003，21，2：	1
10	Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors 显示文摘	Thomas JP Arzoomanian RZ Alberti D	2003	J Clin Oncol2003，21，2：	1
11	Role of combination bortezomib and pegylated liposomal doxorubicin in zhe management of relapsed and/or refractory multiple myeloma 显示文摘	Shah JJ Orlowski RZ Thomas SK	2009	Ther Clin Risk Manag2009，5，1：	1
12	Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors 显示文摘	Thomas JP Arzomarian RZ Alberti D	2003	J Clin Oncol2003，21，2：	1
13	Metabolic effects of albumin therapy in acute lung injury measured by1H-NMR spectroscopy of plasma:a pilot study显示文摘	Youngja P Dean PJ Thomas RZ	2011	Crit Care Med2011，39，10：	1
14	miR-155 promotes T follicular helper cell accumulation during chronic, low-grade in- flammation显示文摘	Hu RZ Dominique AK Thomas BH	2014	Immunity2014，41，4：	1
15	Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors显示文摘	THOMAS JP ARZOOMANIAN RZ ALBERTI D	2003	J Clin Oncol2003，21，2：	1
16	Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors显示文摘	Arzoomanian RZ Alberti D	2003	J Clin Onco2003，21，2：	1
17	Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors 显示文摘	Thomas JP Arzoomanian RZ Alberti D	2003	J Clin Oncol2003，21，：	1
18	Phase l pharmacokinetic and pharmacodynamic study of recombi- nant human endostatin in patients with advanced solid tumors显示文摘	Thomas JP Arzoomanian RZ Alberti D	2003	J Clin Onco2003，21，2：	1
19	Phase Ⅰpharmacokinetis and pharmacodynamic atudy of recombinant human endostatin in patients with advanced solid tumors 显示文摘	Arzoomanian RZ Alberti D	2003	J Clin Oncol2003，21，2：	1
20	Red autofluorescence of dental plaque bacteria显示文摘	van der Veen MH Thomas RZ Huysmans MC	2006	Caries Res2006，40，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示